Debulking procedures not beneficial in patients with end-stage prostate cancer

Article

Primary therapy for prostate cancer does not reduce the frequency of end-of-life urologic procedures, according to the findings of a population-based study.

Related Videos
Illustration of AI | Image Credit: © Tierney - stock.adobe.com
DNA illustration | Image Credit: © BillionPhotos.com - stock.adobe.com
Mara R. Holton, MD, answers a question during a Zoom video interview
Human kidney cross section on science background | Image Credit: © Crystal light - stock.adobe.com
3d rendered illustration of bladder cancer | Image Credit: © SciePro - stock.adobe.com
Paul E. Dato, MD, an expert on prostate cancer
Related Content
© 2023 MJH Life Sciences

All rights reserved.